These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30404909)

  • 1. Patients with type 1 diabetes are missing out on flash glucose devices, finds
    Iacobucci G
    BMJ; 2018 Nov; 363():k4675. PubMed ID: 30404909
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
    Perera R; Oliver N; Wilmot E; Marriott C
    Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
    [No Abstract]   [Full Text] [Related]  

  • 3. NHS misses key performance targets again in June.
    Limb M
    BMJ; 2016 Aug; 354():i4443. PubMed ID: 27516494
    [No Abstract]   [Full Text] [Related]  

  • 4. Flash Glucose Monitoring is associated with improved glycaemic control but use is largely limited to more affluent people in a UK diabetes centre.
    McKnight JA; Gibb FW
    Diabet Med; 2017 May; 34(5):732. PubMed ID: 28103416
    [No Abstract]   [Full Text] [Related]  

  • 5. Variations in access to continuous glucose monitoring and flash glucose sensors for children and young people in England and Wales: a national survey.
    Ferguson EC; Wright N; Regan F; Agwu JC; Williams E; Soni A; Timmis A; Kershaw M; Drew J; Moudiotis C; Ng SM;
    Arch Dis Child; 2020 Jun; 105(6):609-610. PubMed ID: 31527045
    [No Abstract]   [Full Text] [Related]  

  • 6. Pediatric Endocrinologists' Experiences With Continuous Glucose Monitors in Children With Type 1 Diabetes.
    Derrick KM; Heptulla RA
    J Diabetes Sci Technol; 2018 Sep; 12(5):1090-1091. PubMed ID: 29808719
    [No Abstract]   [Full Text] [Related]  

  • 7. Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic.
    Dover AR; Stimson RH; Zammitt NN; Gibb FW
    J Diabetes Sci Technol; 2017 Mar; 11(2):442-443. PubMed ID: 27464754
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
    Hellmund R; Weitgasser R; Blissett D
    Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self monitoring of glucose by people with diabetes. Self monitoring improves quality of life and prognosis of people with diabetes.
    de Alva M; Jervell J
    BMJ; 1997 Jul; 315(7101):184-5. PubMed ID: 9251554
    [No Abstract]   [Full Text] [Related]  

  • 10. RAWP: weighting for a change.
    Appleby J
    Health Serv J; 1995 Jul; 105(5461):34-5. PubMed ID: 10144643
    [No Abstract]   [Full Text] [Related]  

  • 11. Overcrowding: emergency departments are the canary in the coal mine and overcrowding is the poisonous gas.
    Boyle AA; Beniuk K
    Eur J Emerg Med; 2010 Dec; 17(6):354. PubMed ID: 20195156
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in applying diabetes technology to clinical care.
    Peters AL
    Diabetes Technol Ther; 2012 Oct; 14(10):849-50. PubMed ID: 23013199
    [No Abstract]   [Full Text] [Related]  

  • 14. Accessibility and use of health care services in the British Asian community.
    Hawthorne K
    Fam Pract; 1994 Dec; 11(4):453-9. PubMed ID: 7895976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downloading Diabetes Device Information.
    Chase HP; Owen SL; Slover RH
    Diabetes Technol Ther; 2015 Aug; 17(8):534-5. PubMed ID: 26237306
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health State Utilities Associated with Glucose Monitoring Devices.
    Matza LS; Stewart KD; Davies EW; Hellmund R; Polonsky WH; Kerr D
    Value Health; 2017 Mar; 20(3):507-511. PubMed ID: 28292497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring in Type 1 Diabetes Pregnancy Shows that Fetal Heart Rate Correlates with Maternal Glycemia.
    Cypryk K; Bartyzel L; Zurawska-Klis M; Mlynarski W; Szadkowska A; Wilczynski J; Nowakowska D; Wozniak LA; Fendler W
    Diabetes Technol Ther; 2015 Sep; 17(9):619-24. PubMed ID: 25927286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Need-based resource allocation--experiences with the RAWP formula in Great Britain].
    Brand H; Menke R
    Gesundheitswesen; 1997 Jul; 59(7):441-6. PubMed ID: 9333384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices.
    Garg SK; Akturk HK
    Diabetes Technol Ther; 2018 Jun; 20(6):391-394. PubMed ID: 29901411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.